• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

7.410 -0.360 (-4.63%)
Official Closing Price Updated: 7:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Bausch Health Announces Final Results and Expiration of Exchange Offers
December 23, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Early Exchange Offer Results for Exchange Offers
December 08, 2025
Via ACCESS Newswire
News headline image
Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China
December 01, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Offers to Exchange Certain Existing Senior Secured Notes
November 24, 2025
Via ACCESS Newswire
News headline image
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
November 18, 2025
Via ACCESS Newswire
News headline image
Bausch Health's OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease
November 05, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Third Quarter 2025 Results
October 29, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Results of Special Meeting of Shareholders
October 09, 2025
Via ACCESS Newswire
News headline image
Bausch Health's Aesthetic Business, Solta Medical, Brings Non-Invasive Aesthetic Innovations to National TV
September 30, 2025
Via ACCESS Newswire
News headline image
Bausch Health to Announce Third Quarter 2025 Results on October 29
September 30, 2025
Via ACCESS Newswire
News headline image
Bausch Health's OraPharma Introduces "OraTalks," a New Podcast Bringing Bold Conversations to Dentistry
September 29, 2025
Via ACCESS Newswire
News headline image
Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio
September 11, 2025
Via ACCESS Newswire
News headline image
Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage(R) Non-Surgical System
September 05, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Extension of DURECT Corporation Tender Offer to September 10, 2025
August 26, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Increase in Shareholding by its Chairperson of the Board and Board Changes
August 15, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners
August 07, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Second Quarter 2025 Results
July 30, 2025
Via ACCESS Newswire
News headline image
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease
July 29, 2025
Via ACCESS Newswire
News headline image
Bausch Health to Reduce Debt by Approximately $900 Million Using Cash On Hand
July 28, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors
July 24, 2025
Via ACCESS Newswire
News headline image
Bausch Health Appoints New Chief Accounting Officer
July 10, 2025
Via ACCESS Newswire
News headline image
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence
July 07, 2025
Via ACCESS Newswire
News headline image
Bausch Health to Announce Second Quarter 2025 Results on July 30
July 02, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces 2025 Annual Meeting of Shareholder Results
May 14, 2025
Via ACCESS Newswire
News headline image
Xifaxan(R) (rifaximin) Treatment Following Overt Hepatic Encephalopathy (OHE) Hospitalization Associated with Reduced Risk of 30-Day OHE Rehospitalization
May 06, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces First Quarter 2025 Results
April 30, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Health Canada Clearance of Solta Medical's Thermage(R) FLX System
April 29, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Launch of Solta Medical's Fraxel FTX(TM)
April 25, 2025
Via ACCESS Newswire
News headline image
Bausch Health Announces Filing of Supplement to Proxy Statement
April 22, 2025
Via ACCESS Newswire
News headline image
U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich
April 17, 2025
Via ACCESS Newswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap